Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 60687-330

7 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 60687-330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp31921

Ahp31921
Tolterodine Tartrate 2 mg extended-release oral capsules in green color, with one side showing the imprint '1189' and the other side plain. These capsules are labeled by American Health Packaging and intended for human prescription use.*
FDA Label Image

Ahp33021

Ahp33021
Blue extended release capsules of Tolterodine Tartrate shown, one imprinted with '1190' in white. Capsules are smooth and capsule shaped with a glossy finish. No other markings or branding are visible on these oral dosage form capsules.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of Tolterodine Tartrate, showing the molecular arrangement of Tolterodine and tartrate components.*
FDA Label Image

2 mg Tolterodine Tartrate Er Capsules Carton (2 mg Tolterodine Tartrate Er Capsules Carton)

2 mg Tolterodine Tartrate Er Capsules Carton (2 mg Tolterodine Tartrate Er Capsules Carton)
Packaging label for Tolterodine Tartrate Extended-Release Capsules, USP 2 mg, containing 30 capsules (3 x 10) by American Health Packaging. The label includes dosage form, strength, package amount, NDC 60687-319-21, barcode, and storage instructions.*
FDA Label Image

2mg Tolterodine Tartrate Tablet Blister (2mg Tolterodine Tartrate Tablet Blister)

2mg Tolterodine Tartrate Tablet Blister (2mg Tolterodine Tartrate Tablet Blister)
Tolterodine Tartrate Extended-Release Capsule, USP 2 mg packaging label from American Health Packaging. The label shows the product name, strength (2 mg), dosage form (extended-release capsule), lot number (1234567), and expiration date (2025-10-17). The label includes barcodes and is arranged in multiple identical unit labels.*
FDA Label Image

4 mg Tolterodine Tartrate Er Capsules Carton (4 mg Tolterodine Tartrate Er Capsules Carton)

4 mg Tolterodine Tartrate Er Capsules Carton (4 mg Tolterodine Tartrate Er Capsules Carton)
Tolterodine Tartrate 4 mg Extended-Release Capsules, USP, oral dosage form. The label shows a package containing 30 capsules (3 x 10) by American Health Packaging. Includes dosage strength, quantity, storage instructions, caution not to use if blister is damaged, barcode, NDC 60687-330-21, and a QR code for prescribing information.*
FDA Label Image

4 mg Tolterodine Tartrate Er Capsule Blister (4 mg Tolterodine Tartrate Er Capsule Blister)

4 mg Tolterodine Tartrate Er Capsule Blister (4 mg Tolterodine Tartrate Er Capsule Blister)
Tolterodine Tartrate Extended-Release Capsules, USP 4 mg, manufactured by American Health Packaging. The labels include the drug name, dosage strength (4 mg), capsule dosage form, lot number 1234567, and expiration date 2025-12-04. Each label also shows multiple barcodes and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.